| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/06/2013 | EP2660248A1 Novel immunotherapy against neuronal and brain tumors |
| 11/06/2013 | EP2660247A2 High penetration prodrug compositions of peptides and peptide-related compounds |
| 11/06/2013 | EP2659904A1 Use of Hsp70 as a regulator of enzymatic activity |
| 11/06/2013 | EP2659903A2 Nanoemulsion-type ophthalmic composition |
| 11/06/2013 | EP2659902A1 Leuprolide injection |
| 11/06/2013 | EP2659901A1 Recombinant deamidated gliadin antigen |
| 11/06/2013 | EP2659885A1 Hepatitis C Antiviral Compositions and Methods |
| 11/06/2013 | EP2659271A1 Therapeutic and diagnostic methods involving biglycan and utrophin |
| 11/06/2013 | EP2659267A1 Cmet protein srm/mrm assay |
| 11/06/2013 | EP2658979A1 Compositions comprising natriuretic peptides and methods of use thereof |
| 11/06/2013 | EP2658972A2 Melanoma treatments |
| 11/06/2013 | EP2658867A1 Non-natural mic proteins |
| 11/06/2013 | EP2658574A1 Polymalic acid-based nanobiopolymer compositions and methods for treating cancer |
| 11/06/2013 | EP2658567A1 Methods of modifying insulin signaling using biliverdin reductase (bvr) and bvr derived peptides |
| 11/06/2013 | EP2658566A1 Sirna against cbl-b and optionally il2 und il12 for use in the treatment of cancer |
| 11/06/2013 | EP2658565A2 Methods for improving fracture healing and bone formation |
| 11/06/2013 | EP2658564A1 Methods and systems for treatment of migraines and other indications |
| 11/06/2013 | EP2658560A1 A nutritional composition comprising fiber and probiotics for reducing stress-related intestinal symptoms |
| 11/06/2013 | EP2658559A1 Fiber and probiotics for reducing intestinal symptoms related to stress |
| 11/06/2013 | EP2658544A2 Oxidosqualene cyclase as a protein target for anticancer therapeutics |
| 11/06/2013 | EP2658529A2 Ocular drug delivery system |
| 11/06/2013 | EP2658396A1 Use of nutritional compositions including lactoferrin in stimulating immune cells |
| 11/06/2013 | EP2658389A1 Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions |
| 11/06/2013 | EP2658388A2 Method for inhibiting pathogens using a nutritional composition |
| 11/06/2013 | EP2359853B1 Pharmaceutical compositions and methods useful for modulating angiogenesis |
| 11/06/2013 | CN1856572B Use of RNAi inhibiting PARP activtiy for the manufacture of a medicament for the treatment of cancer |
| 11/06/2013 | CN103384722A Plasminogen and plasmin variants |
| 11/06/2013 | CN103384679A Recombinant laminin-521 |
| 11/06/2013 | CN103384529A Methods and compositions suitable for managing blood glucose in animals |
| 11/06/2013 | CN103384528A Biodegradable drug delivery composition |
| 11/06/2013 | CN103382463A Ocean Sipunculus nudus plasmin and its preparation and application |
| 11/06/2013 | CN103382462A Bacillus licheniformis lysozyme and its production method and application thereof |
| 11/06/2013 | CN103382220A Cell factor FAM19A4 with anti-infection and antineoplastic activity and application thereof |
| 11/06/2013 | CN103382216A Cyanoisoquinoline compounds and methods of use thereof |
| 11/06/2013 | CN103381267A Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions |
| 11/06/2013 | CN103381136A Edible cosmetics and preparation method thereof |
| 11/06/2013 | CN103110933B Elcatonin composition and preparation method thereof |
| 11/06/2013 | CN102940876B Application of polypeptide GH27 in preparation of medicament for preventing and treating goat diarrhea |
| 11/06/2013 | CN102920994B Pharmaceutical composition containing animal bone polypeptide |
| 11/06/2013 | CN102743741B Preparation of blattodea polypeptide, and uses of the same in anti-gram-positive bacteria and anti-gram-negative bacteria |
| 11/06/2013 | CN102743739B Preparation method for blattodea polypeptide substance, and medical use of blattodea polypeptide substance in anti-herpesvirus |
| 11/06/2013 | CN102675421B Epitope peptide of heat shock protein and application thereof |
| 11/06/2013 | CN102659922B Peptide Derived From Hepatitis C Virus |
| 11/06/2013 | CN102631669B Nutritional breast patch and preparation method thereof |
| 11/06/2013 | CN102631662B Composition with functions of protecting liver and relieving fatigue and preparation method of composition |
| 11/06/2013 | CN102585015B Fusion protein containing glicetin-1 as well as preparation method and application |
| 11/06/2013 | CN102584974B Acipenser sinensis antibacterial peptide and preparation method and application thereof |
| 11/06/2013 | CN102552884B Weight loss secret recipe of Zhuang medicine |
| 11/06/2013 | CN102552879B Composition of pulmonary surfactant extract and pulmonary surfactant-associated protein A, preparation method and pharmaceutical application thereof |
| 11/06/2013 | CN102525927B Octreotide acetate preparation and preparation method thereof |
| 11/06/2013 | CN102516364B Active peptide for simulating porcine growth hormone-like effect, preparation method for active peptide and application of active peptide |
| 11/06/2013 | CN102516360B Polypeptide capable of inhibiting beta-secretase digestion effect and application thereof |
| 11/06/2013 | CN102399295B Low-sulfhydrylation-modification-degree biocompatible high-molecular sulfhydrylation derivatives, cross-linking material thereof, and purpose thereof |
| 11/06/2013 | CN102391377B Fusion protein capable of inducing and activating cancer targeting T-cells as well as preparation method and application of the fusion protein |
| 11/06/2013 | CN102336802B Glycyrrhetinic acid-modified lipid, liver targeting liposome, micelle and compound, and their preparation method |
| 11/06/2013 | CN102333520B Prophylactic/therapeutic agent for cancer |
| 11/06/2013 | CN102086466B Almond functional hybrid peptide and preparation method thereof |
| 11/06/2013 | CN102066559B Biotechnological production of cyanophycin dipeptides |
| 11/06/2013 | CN102066402B Peptide derivative and composition for promoting tear secretion comprising the same |
| 11/06/2013 | CN102065929B System for stimulation of cartilage formation using reduced pressure treatment |
| 11/06/2013 | CN102038932B Metal-binding compounds and uses therefor |
| 11/06/2013 | CN102036690B Novel soluble CD83 polypeptides, formulations and methods of use |
| 11/06/2013 | CN101982458B 3-amino-3-arylpropionic acid and preparation method thereof |
| 11/06/2013 | CN101835892B CDCA1 peptide and pharmaceutical agent comprising the same |
| 11/06/2013 | CN101678213B Cyclic peptide cxcr4 antagonists |
| 11/06/2013 | CN101648004B Medicinal composition for treating eye diseases and application thereof |
| 11/06/2013 | CN101641371B 肽及其用途 Peptides and their uses |
| 11/06/2013 | CN101628111B Taci-immunoglobulin fusion proteins |
| 11/06/2013 | CN101611320B Method for assaying antibodies in body fluids by immune reaction with glycoprotein 2 (gp2) from zymogenic granules of the pancreas for the diagnosis of inflammatory intestinal diseases and chronic pan |
| 11/06/2013 | CN101573376B Selective glucagon-like-peptide-2 (GLP-2) analogues |
| 11/06/2013 | CN101568350B Lipidized interferon and uses thereof |
| 11/06/2013 | CN101554237B Preparation method of oxalate-degrading enzyme contained in plant fiber or microorganism indissolvable component |
| 11/06/2013 | CN101506238B Methods and compositions with enhanced therapeutic activity |
| 11/06/2013 | CN101454341B Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation |
| 11/06/2013 | CN101448851B Improved antimicrobial peptides |
| 11/06/2013 | CN101302515B Human antibodies that bind human TNF(alpha) |
| 11/06/2013 | CN101273042B Macrocyclic inhibitors of hepatitis C virus |
| 11/06/2013 | CN101189334B 抗cd14抗体融合蛋白质 Anti-cd14 antibody fusion proteins |
| 11/06/2013 | CN101076345B Medicine for preventing and curing human genital system disorder and method for manufacturing the same |
| 11/06/2013 | CN101073667B Enhancer for antibody to lymphocytic tumors |
| 11/05/2013 | US8575313 Process for extracting keratin |
| 11/05/2013 | US8575309 Delta-opioid receptor selective analgesics |
| 11/05/2013 | US8575308 Method for cancer immunotherapy |
| 11/05/2013 | US8575307 Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetes |
| 11/05/2013 | US8575304 MEK ligands and polynucleotides encoding MEK ligands |
| 11/05/2013 | US8575198 In-process control for the manufacture of glatiramer acetate |
| 11/05/2013 | US8575169 Method of treating sexual dysfunctions with delta opioid receptor agonist compounds |
| 11/05/2013 | US8575113 BIR domain binding compounds |
| 11/05/2013 | US8575112 Small peptide modulators of potassium channel trafficking |
| 11/05/2013 | US8575111 Pharmaceutical compositions and methods for treating erectile dysfunction |
| 11/05/2013 | US8575110 Peptidic nanoparticles as drug delivery and antigen display systems |
| 11/05/2013 | US8575109 Recombinant pokeweed antiviral proteins, compositions and methods related thereto |
| 11/05/2013 | US8575108 Cyclosporin compositions |
| 11/05/2013 | US8575107 Clusterin derived peptide |
| 11/05/2013 | US8575106 Cosmetic uses of modified stressed yeast extracts and related compositions |
| 11/05/2013 | US8575104 Factor VIII, von willebrand factor or complexes thereof with prolonged in vivo half-life |
| 11/05/2013 | US8575103 Peptides and methods for inhibiting G alpha protein signaling |
| 11/05/2013 | US8575102 Conjugates having a releasable linkage |
| 11/05/2013 | US8575101 Supplemented matrices for the repair of bone fractures |
| 11/05/2013 | US8575100 Tc and Re labeled radioactive glycosylated octreotide derivatives |